NO20075507L - Tiazolidindionderivater og deres anvendelse som antidiabetiske midler - Google Patents

Tiazolidindionderivater og deres anvendelse som antidiabetiske midler

Info

Publication number
NO20075507L
NO20075507L NO20075507A NO20075507A NO20075507L NO 20075507 L NO20075507 L NO 20075507L NO 20075507 A NO20075507 A NO 20075507A NO 20075507 A NO20075507 A NO 20075507A NO 20075507 L NO20075507 L NO 20075507L
Authority
NO
Norway
Prior art keywords
antidiabetic agents
compound
thiazolidinedione derivatives
thiazolidinedione
derivatives
Prior art date
Application number
NO20075507A
Other languages
English (en)
Inventor
Michael John Millan
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9900427&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20075507(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Publication of NO20075507L publication Critical patent/NO20075507L/no
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

En forbindelse 5-[4-[2-(N-metyl-N-(2-pyridyl)amino)etoksy]-benzyl]tiazohdin-2,4-dion kaliumsalt eller et farmasøytisk akseptabelt solvat derav, en farmasøytisk sammensetning som inneholder en slik forbindelse og anvendelse av en slik forbindelse innen medisin, særlig ved behandling av diabetes mellitus.
NO20075507A 2000-09-29 2007-10-31 Tiazolidindionderivater og deres anvendelse som antidiabetiske midler NO20075507L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0023970.7A GB0023970D0 (en) 2000-09-29 2000-09-29 Novel pharmaceutical
PCT/GB2001/004346 WO2002026736A1 (en) 2000-09-29 2001-09-28 A thiazolidinedione derivative and its use as antidiabetic

Publications (1)

Publication Number Publication Date
NO20075507L true NO20075507L (no) 2003-05-27

Family

ID=9900427

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20031434A NO324970B1 (no) 2000-09-29 2003-03-28 Farmasoytisk preparat omfattende 5-[4-[2-(N-metyl-N-(2-pyridyl)amino)etoksy]-benzyl]tiazolidin-2,4-dionkaliumsalt samt anvendelse av saltet
NO20075507A NO20075507L (no) 2000-09-29 2007-10-31 Tiazolidindionderivater og deres anvendelse som antidiabetiske midler

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO20031434A NO324970B1 (no) 2000-09-29 2003-03-28 Farmasoytisk preparat omfattende 5-[4-[2-(N-metyl-N-(2-pyridyl)amino)etoksy]-benzyl]tiazolidin-2,4-dionkaliumsalt samt anvendelse av saltet

Country Status (34)

Country Link
US (1) US20040038968A1 (no)
EP (2) EP1795531A1 (no)
JP (1) JP2004509960A (no)
KR (2) KR20070089258A (no)
CN (2) CN1620453B (no)
AP (1) AP1841A (no)
AT (1) ATE368038T1 (no)
AU (2) AU9203401A (no)
BG (1) BG107678A (no)
BR (1) BR0114364A (no)
CA (1) CA2423978A1 (no)
CY (1) CY1107767T1 (no)
CZ (1) CZ2003849A3 (no)
DE (1) DE60129576T2 (no)
DK (1) DK1325000T3 (no)
DZ (1) DZ3481A1 (no)
EA (1) EA005110B1 (no)
EC (1) ECSP034529A (no)
ES (1) ES2290169T3 (no)
GB (1) GB0023970D0 (no)
HK (1) HK1058192A1 (no)
HU (1) HUP0301199A3 (no)
IL (2) IL155140A0 (no)
MA (1) MA25913A1 (no)
MX (1) MXPA03002867A (no)
NO (2) NO324970B1 (no)
NZ (1) NZ524932A (no)
OA (1) OA12400A (no)
PL (1) PL361157A1 (no)
PT (1) PT1325000E (no)
SK (1) SK3792003A3 (no)
UA (1) UA76121C2 (no)
WO (1) WO2002026736A1 (no)
ZA (1) ZA200302438B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU225919B1 (en) * 1999-12-18 2007-12-28 Richter Gedeon Nyrt Thiazolidine-derivatives, process for their preparation pharmaceutical and intermediates
HUP0800755A2 (en) 2008-12-11 2010-09-28 Richter Gedeon Nyrt Crystalline forms of rosiglitazone

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0842925A1 (en) * 1987-09-04 1998-05-20 Beecham Group Plc Substituted thiazolidinedione derivatives
US5646169A (en) * 1987-09-04 1997-07-08 Beecham Group P.L.C. Compounds for treating eating disorders in which blood glucose levels are raised
GB9124513D0 (en) * 1991-11-19 1992-01-08 Smithkline Beecham Plc Novel process
GB9308487D0 (en) * 1993-04-23 1993-06-09 Smithkline Beecham Plc Novel compounds
GB9712866D0 (en) * 1997-06-18 1997-08-20 Smithkline Beecham Plc Novel method of treatment
GB9723295D0 (en) * 1997-11-04 1998-01-07 Smithkline Beecham Plc Novel process
CN1183130C (zh) * 1999-09-24 2005-01-05 中国人民解放军军事医学科学院毒物药物研究所 噻唑烷类衍生物及其医药用途
HU225919B1 (en) * 1999-12-18 2007-12-28 Richter Gedeon Nyrt Thiazolidine-derivatives, process for their preparation pharmaceutical and intermediates

Also Published As

Publication number Publication date
NO324970B1 (no) 2008-01-14
IL155140A (en) 2010-06-30
OA12400A (en) 2004-09-06
NO20031434L (no) 2003-05-27
WO2002026736A1 (en) 2002-04-04
IL155140A0 (en) 2003-10-31
MA25913A1 (fr) 2003-10-01
ECSP034529A (es) 2003-05-26
CN1620453B (zh) 2010-12-08
EP1325000A1 (en) 2003-07-09
JP2004509960A (ja) 2004-04-02
CY1107767T1 (el) 2013-04-18
HUP0301199A3 (en) 2005-04-28
CZ2003849A3 (cs) 2004-03-17
ATE368038T1 (de) 2007-08-15
NZ524932A (en) 2005-06-24
KR100822135B1 (ko) 2008-04-15
BG107678A (bg) 2003-11-28
AP1841A (en) 2008-04-30
DE60129576T2 (de) 2008-04-17
UA76121C2 (en) 2006-07-17
HUP0301199A2 (hu) 2003-11-28
MXPA03002867A (es) 2004-12-06
ZA200302438B (en) 2004-04-28
BR0114364A (pt) 2003-12-09
KR20030032058A (ko) 2003-04-23
AP2003002766A0 (en) 2003-03-31
EP1795531A1 (en) 2007-06-13
DK1325000T3 (da) 2007-11-12
CA2423978A1 (en) 2002-04-04
SK3792003A3 (en) 2004-04-06
DZ3481A1 (fr) 2002-04-04
DE60129576D1 (de) 2007-09-06
PT1325000E (pt) 2007-10-25
AU9203401A (en) 2002-04-08
NO20031434D0 (no) 2003-03-28
AU2001292034B2 (en) 2005-04-21
GB0023970D0 (en) 2000-11-15
EA200300423A1 (ru) 2003-08-28
CN1620453A (zh) 2005-05-25
HK1058192A1 (en) 2004-05-07
KR20070089258A (ko) 2007-08-30
ES2290169T3 (es) 2008-02-16
PL361157A1 (en) 2004-09-20
CN101961333A (zh) 2011-02-02
EP1325000B1 (en) 2007-07-25
EA005110B1 (ru) 2004-10-28
US20040038968A1 (en) 2004-02-26

Similar Documents

Publication Publication Date Title
AR057970A2 (es) Composiciones farmaceuticas para el tratamiento de la diabetes mellitus y condiciones asociadas con la diabetes mellitus y procedimientos para preprar dichas composiciones
CY1106226T1 (el) Μεσυλικο αλας 5-[4-[2-(ν-μεθυλ-ν-(2-πυριδυλ)αμινο)αιθοξυ]βενζυλ]θειαζολιδινο-2,4-διονης
NO20075507L (no) Tiazolidindionderivater og deres anvendelse som antidiabetiske midler
CY1105354T1 (el) Ένα παραγωγο θειαζολιδινοδιονης και η χρηση του σαν αντι-διαβητικο
NO20076517L (no) Natriumsalter av 5-[4-[2-(N-metyl-N-(2-pyridyl)amino)etoksyl]benzyl]tiazolidin-2,4-dion
AP1814A (en) Tartrate salts of thiazolidinedione derivative.
DK1446404T3 (da) Rosiglitazonedisylater og deres anvendelse som antidiabetika
AP1715A (en) The hydrochloride salt of 5-[ 4 -[2 -(n-methyl-n- (2-pyridyl) amino) ethoxy]benzyl]thiazolidine -2,4-dione
MXPA02012100A (es) Sal de tiazodilindiona para el tratamiento de la diabetes mellitus.
DK1315721T3 (da) Et Thiazolidindionderivat og dets anvendelse som et antidiabetisk middel
AP1785A (en) Tartrate salt of thiazolidinedione derivative.
AP2002002684A0 (en) 5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2-pyridyl) amino) ethoxy)benzyl) thiazolidine-2,4-dione hydriodide as pharmaceutical
NO20030531L (no) Tartratsalter av tiazolidindionderivater
HK1068884A1 (en) 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyleof; and its use as pharmaceutical active ingredie)thiazolidine-2,4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thernt